The Indian government has received requests from several pharma machinery producers to curtail the free flow imports of Chinese machineries by imposing anti dumping duty.
Presenting a set of recommendations to the country's union commerce ministry, the domestic makers claimed that unrestricted imports have threatened the survival of their businesses, as reported by Pharmabiz.com.
Urging the government to dictate some regulatory framework on par with the WHO-GMP standards for the pharma machinery manufacturing sector, the industry leaders also asked government support for R&D, export promotion schemes, funding for foreign market development.
The industry has also sought government help for financing and risk coverage for exports to under developed countries, relaxations for import of design and technology, education on patent laws and process to protect designs.
They also requested that pharma machineries should be made a part of bilateral agreements with LAC countries, European and other countries for duty free imports at purchaser's side.
It is estimated that around 800 Indian pharmaceutical machine manufacturing and allied utility service units in the small and medium sector (SME) are engaged in processing, packaging, material handling, R&D equipment & instrumentation, and API/bulk drug plant machineries.
A study has highlighted that Indian pharma machinery industry is developing at 15 to 20% annually, with a reported projected revenue of about INR60bn ($1.01bn), out of which INR18bn ($303m) account for exports.(Published 16 July 2013)
Source:-manufacturing.pharmaceutical-business-review.com
No comments:
Post a Comment